A Wearable and a Self-management Application for Chronic Obstructive Pulmonary Disease (COPD) Patients at Home
COPDwear
COPDwear V2 - A Wearable and a Self-management Application for COPD Patients at Home: a Pilot Prospective Cohort Study
1 other identifier
observational
30
1 country
1
Brief Summary
Our overall research goal for this project is to create a wearable device and mobile application, appealing to patients with Chronic Obstructive Pulmonary Disease (COPD), which provides them with appropriate self-management tools and detects AECOPDs early to permit prompt treatment and prevent severe exacerbations requiring hospitalization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2018
CompletedFirst Posted
Study publicly available on registry
February 27, 2019
CompletedStudy Start
First participant enrolled
June 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedJanuary 24, 2025
January 1, 2025
1.9 years
July 23, 2018
January 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in self-management as measured by the Mastery sub-section of the Chronic Respiratory Disease Questionnaire
Can an app designed for patients with COPD that includes biosensor feedback improve self-management of COPD? We will use the Mastery sub-section of the Chronic Respiratory Disease Questionnaire to measure our research question. Mastery is measured with a 7-point likert scale where higher scores indicate better health-related mastery.
6 months
Secondary Outcomes (4)
Change in self-efficacy as measured by the COPD Self-Efficacy Scale
6 months
Change in Health related quality of life as measured by the St. George's respiratory questionnaire
6 months
Change in symptom scale as measured by the MRC dyspnea scale
6 months
Accuracy of our derived prediction algorithm to detect acute exacerbations as measured by the daily symptom score.
6 months
Study Arms (1)
COPD Patients
This is a prospective cohort study enrolling patients with COPD to 1) wear a smartwatch that passively senses heart rate, motion, audio, 2) use a smartphone that can obtain oxygen saturation upon demand, 3) use a self-management app on the smartwatch, smartphone and a webapp.
Interventions
WearCOPD2 consists of hardware and software components. 6.1 Hardware The hardware for wearCOPDv2 consists of three main components; (1) a smartwatch, (2) a phone, and (3) a server. 6.2 Software The wearCOPDv2 system has two main software components: 1. Data collection service 2. Participant user interface
Eligibility Criteria
The investigators will recruit patients who have clinically relevant COPD who live at home. They will be identified in clinics and the wards by members of their care team. Posters informing people of the study will also be posted at University Health Network (UHN) with a contact number.
You may qualify if:
- Able to speak English
- Moderate to very severe COPD (GOLD C and D) as defined by the GOLD guidelines
- Clinically relevant disease, as defined by a history of exacerbation in the previous 12 months
- Previous spirometry or Pulmonary Function Test results of Forced Expiration Volume/Forced Vital Capacity (FEV1/FVC) \<0.70 with an FEV1 below 80% predicted
- Patient resides at home (not long term care residence or another hospital)
You may not qualify if:
- Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma
- Rapid lethal disease, e.g. lung cancer, advance heart failure, end-stage renal disease
- Any medical conditions that would impair their ability to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- University of Torontocollaborator
- Samsung Electronicscollaborator
Study Sites (1)
Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
Related Publications (1)
Wu R, de Lara E, Liaqat D, Liaqat S, Chen JL, Son T, Gershon AS. Feasibility of a wearable self-management application for patients with COPD at home: a pilot study. BMC Med Inform Decis Mak. 2024 Mar 5;24(1):66. doi: 10.1186/s12911-024-02461-y.
PMID: 38443858DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Wu
University Health Network, Toronto
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- General Internal Medicine Site Director
Study Record Dates
First Submitted
July 23, 2018
First Posted
February 27, 2019
Study Start
June 29, 2019
Primary Completion
June 1, 2021
Study Completion
December 30, 2023
Last Updated
January 24, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will become available right away for up to 5 years.
- Access Criteria
- Data will be stored and analyzed on the secure UHN server
UHN, research personnel will have direct access to the source documents with identifying information. UHN, University of Toronto (UofT) and Samsung Research America (SRA) will have access to the anonymized subject data for analysis purposes.